Download presentation
Presentation is loading. Please wait.
Published byCorey Lester Modified over 6 years ago
1
The Pathogenesis of Diseases from Genetic and Genomic Point of View
Oliver Rácz and František Ništiar Institute of Pathological Physiology Medical School, Šafárik University 2009 – 2016 gene16a
2
26th june 2000 is neither the beginning nor the end of the way
5 years before term ( ) The race is over, victory for Craig Venter. The genome is mapped* - now what ? Not a discovery! A very important technological result and competition is always useful. all is based on Mendel‘s and Watson‘s & Crick‘s discoveries in XIXth XXth century *3*109 letters gene16a
3
Mendel, Watson, Crick & the medical genetics of XIXth – XXth century
Mendel‘s laws are valid also today Watson & Crick provided the material basis of these laws (central dogma of molecular biology) Mendel‘s laws in medicine can be applied to monogenic diseases – long list, relatively rare What is the genetics of diabetes, hypertension, coronary heart disease, Alzheimer disease ? gene16a
4
White flower from red parents ???
gene16a
5
gene16a
6
Quidditch ball for Harry Potter ?
gene16a
7
We discovered the secret of life, let’s have a beer!
gene16a
8
gene16a
9
Central dogma of molecular biology (cca. 1965)
Replication Transcription Translation Transformation DNA DNA RNA PROTEIN A B gene16a
10
gene16a
11
Central dogma of molecular biology? – not so simple
DNA DNA RNA PROTEIN A B gene16a
12
Central dogma of molecular biology? Epigenetics ? Role of RNA?
Regulation of transcription Transcription factors, etc. Methylation, acetylation… Regulation of RNA editing Alternative splicing Regulation of RNA transport Regulation of translation siRNA, tRNA modifications Postsynthetic modifications gene16a
13
Central dogma of molecular biology
gene16a
14
Central dogma of molecular biology (now) – role of RNAs
Replication Transcription Translation Transformation DNA DNA RNA PROTEIN A B gene16a
15
We and our relatives Organism Genome size chromosomes/ genes
Homo sapiens 23/30 000 Mus musculus 20/30 000 D. Melanogaster 4/13 000 C. Elegans 6/19 000 S. Cerevisiae 18/6 000 E. Coli {1}3 200 HIV virus 9 700 9 A. Thaliana ?/25 000 gene16a
16
It is a little more complicated
DNA DNA RNA PROTEIN A B DNA DNA RNA PROTEIN A B DNA DNA RNA PROTEIN A B DNA DNA RNA PROTEIN A B DNA DNA RNA PROTEIN A B DNA DNA RNA PROTEIN A B DNA DNA RNA PROTEIN A B DNA DNA RNA PROTEIN A B DNA DNA RNA PROTEIN A B DNA DNA RNA PROTEIN A B DNA DNA RNA PROTEIN A B gene16a
17
What is not “genetic” The number of human genes is as low as 30 000
the small worm C. elegans has genes the mouse has as many genes as we, also with very similar function The mystery is in complexity and networking: >>>> (possible on/off states) And a number of surprises around transcription and translation (miRNA, tRNA modifications) It is mapped but do we understand it? GENETICS = HEREDITY GENOMICS = EVERYTHING gene16a
18
GENES AND THE ENVIRONMENT
GENOME ENVIRONMENT A SEVERE MONOGENIC DISEASES NEGATIVE AND POSITIVE ENVIRONMENTAL FACTORS physical chemical biological nutrition life style B POLYMORPHISMS C GENETIC RISK gene16a
19
GENES AND THE ENVIRONMENT
GENOME ENVIRONMENT A THE DNA IS A DEAD MOLECULE COMMUNICATES WITH THE ENVIRONMENT THROUGH EPIGENETIC MECHANISMS DNA methylation Histone modification siRNA SEVERE MONOGENIC DISEASES NEGATIVE AND POSITIVE ENVIRONMENTAL FACTORS physical chemical biological nutrition life style B LESS IMPORTANT MUTATIONS C GENETIC RISK gene16a
20
Genes and diseases in practical medicine
XIXth Century: symptom Þ diagnosis sugar in urine = diabetes XXth Century: symptom ß etiopatogenesis Þ diagnosis autoimmune destruction of b cells = dm Type 1 XXIst Century: symptom ß genes and environment ß susceptibility + overeating = subtypes of dm Type 2 gene16a
21
Mutations changes of genetic information
THREE PRINCIPAL POSSIBILITIES changes in genome not compatible with life development and diversity disease or increased risk fo disease* THE BASIC DIFFERENCE FOR HEREDITY: somatic and germ cell mutations genome, chromosomal and gene mutations no genes for diseases! – sickle cell, Alzheimer, diabetes... gene16a
22
Everything is clear? CTT ACT GCC GGT TCG..........TGA
EACH AMINOACID IS CODED BY THREE CONSECUTIVE NUCLEOTIDES (TRIPLETS, CODONS) CTT ACT GCC GGT TCG TGA Leu Thr Ala Gly Ser STOP OK, silent, missense, nonsense, frameshift AND THE NONCODING SEQUENCES ? gene16a
23
Everything is clear? BUT
CTT ACT GCC GGT TCG TGA Leu Thr Ala Gly Ser STOP BUT IN THE GENOME THERE IS MORE NONCODING (REALLY NONCODING?!) SEQUENCES AS CODING INTRONS IN THE GENES REGULATION (SWITHCES) REPETITIVE SEQENCES (IN MAN UP TO 50 % ) LINE 6000 bp, SINE bp, DIRT (PSEUDOGENES, FOREIGN GENES) TELOMERES (STABILISATION OF CHROMOSOMES) gene16a
24
Gene mutations and SNPs*
Point mutations in exons Frameshift mutation in exons (1,2,4,5...) Small deletion of triplets (3,6...) Bigger deletions – transition to chromosomal aberrations Mutations or polymorphisms in regulatory parts, introns, genes for r-tRNA = SNP, 10*more than the classic mutations Variability of repeated sequences - markers Dynamic mutations – triple repeat mutations *SINGLE NUCLEOTID POLYMORPHISM gene16a
25
CLASSIC MONOGENIC DISASES
Autosomal recessive (AR) Sickle cell disase, other Hbpathies, thalassemias Cystic fibrosis Inborn errors of metabolism Autosomal dominant (AD) Polydactylia Familial hypercholesterolemia Polycystic kidney disease X chromosome linked diseases Heamophilia A, B Daltonism gene16a
26
Autosomal recessive (AR)
Two healthy (carrier heterozygotes) hidden in the population Probability of ill (homozygote) children 1:4 (25%) High number of relatively rare diseases, often fatal Autosomal dominant One ill heterozygote parent Probablity of transfer to next generation 50% Survival is better – “low penetration and expression” 2 * why X chromosome linked diseases Healthy heterozygote mother Probablity of ill sons 50 % (Charles, William, George) gene16a
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.